Adial Pharmaceuticals, Inc. (ADIL) Net income 2017–2025
Adial Pharmaceuticals, Inc. (ADIL) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$8.0MFY2025 · since FY2017: -$1.1M → -$8.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.0M | +39.6% |
| FY2024 | -$13.2M | -157.6% |
| FY2023 | -$5.1M | +59.8% |
| FY2022 | -$12.7M | +34.5% |
| FY2021 | -$19.4M | -78.3% |
| FY2020 | -$10.9M | -26.8% |
| FY2019 | -$8.6M | +26.1% |
| FY2018 | -$11.6M | -920.8% |
| FY2017 | -$1.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice